PMBCL

2

Review clinical trials related to PMBCL. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Axatilimab + CAR-T for High-Risk Lymphoma

Axatilimab + CAR-T in High-Risk Lymphoma

Participants needed: 29
Trial details
Phase: Phase 1Age: 8+Biological sex: AllType: InterventionalSponsor: Northside Hospital, Inc.Updated: Jun 10, 2026Locations: 1
Eligibility criteria

Age ≥ 18 years [+9]

KPS <60 [+9]

Status: Recruiting

Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma

This study is designed to characterize the safety, tolerability, and anti-tumor activity of MDX2003 in patients with different types of lymphoma

Participants needed: 180
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: ModeX Therapeutics, An OPKO Health CompanyUpdated: May 4, 2026Locations: 2
Eligibility criteria

Participant must be ≥ 18 years of age. [+8]

Known or suspected history of hemophagocytic lymphohistiocytosis (HLH). [+8]